Liver tumors in childhood are rare. Approximately two-thirds of all pediatric liver tumors are
malignant, including hepatoblastoma (HB; 37%), hepatocellular carcinoma (HCC; 21%), and …

Infantile hepatic hemangioma (IHH) is a common vascular tumor, distinctive for its perinatal
presentation, rapid growth during the first year of life, and subsequent involution. Although …

Background Hepatoblastoma is a rare disease that nevertheless accounts for the majority of
liver malignancies in children. Due to limited epidemiological data, therapy for …

VC 2013 American Association for the Study of Liver Diseases. of the American Association
for the Study of Liver Diseases requires a class (reflecting the benefit versus the risk) and …

Objectives This study evaluates current trends in incidence, clinical outcomes and factors
predictive of survival in children with hepatoblastoma (HB). Methods The Surveillance …

Background/purpose The purpose of this study was to clarify the role of pulmonary
metastasectomy in hepatoblastomas with lung metastasis at diagnosis. We reviewed cases …

BACKGROUND/PURPOSE: The aim of the study was to analyze changing management
and survival of children with hepatoblastoma (HBL) treated in one center. MATERIALS AND …

Orthotopic liver transplantation (OLT) is currently incorporated into the treatment regimens
for specific nonhepatocellular malignancies. For patients suffering from early‐stage …

Solid tumors account for approximately 30% of all pediatric cancers. Although chemotherapy
has largely contributed to strongly improve patient outcome, multidrug resistance (MDR) …

In children with hepatocellular carcinoma (pHCC) the 5-year overall survival rate is poor.
Effects of cytostatic therapies such as cisplatin and doxorubicin are limited due to …